Literature DB >> 23622405

Metabolic disorders of purine metabolism affecting the nervous system.

H A Jinnah1, Richard L Sabina, Georges Van Den Berghe.   

Abstract

The purines are a group of molecules used by all cells for many vital biochemical processes including energy-requiring enzymatic reactions, cofactor-requiring reactions, synthesis of DNA or RNA, signaling pathways within and between cells, and other processes. Defects in some of the enzymes of purine metabolism are known to be associated with specific clinical disorders, and neurological problems may be a presenting sign or the predominant clinical problem for several of them. This chapter describes three disorders for which the clinical features and metabolic basis are well characterized. Deficiency of adenylosuccinate-lyase (ADSL) causes psychomotor retardation, epilepsy, and autistic features. Lesch-Nyhan disease is caused by deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) and is characterized by hyperuricemia, motor and cognitive disability, and self-injurious behavior. Deficiency of myoadenylate deaminase (mAMPD) is associated with myopathic features. In addition to these disorders, several other disorders are briefly summarized. These include defects of phosphoribosylpyrophosphate synthase, adenosine deaminase (ADA), purine nucleoside phosphorylase (PND), deoxyguanosine kinase (dGK), or IMP dehydrogenase (IMPDH). Each of these disorders provides an unusual window on the unique importance of purine metabolism for function of different parts of the nervous system.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23622405      PMCID: PMC4215161          DOI: 10.1016/B978-0-444-59565-2.00052-6

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  30 in total

Review 1.  Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways.

Authors:  J Vockley; P Rinaldo; M J Bennett; D Matern; G D Vladutiu
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

2.  Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency?

Authors:  M Holder-Espinasse; S Marie; G Bourrouillou; I Ceballos-Picot; M-C Nassogne; L Faivre; J Amiel; A Munnich; M-F Vincent; V Cormier-Daire
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

3.  Autism and adenylosuccinase deficiency.

Authors:  S L Stathis; D M Cowley; D Broe
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-03       Impact factor: 8.829

4.  The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families.

Authors:  J G Puig; R J Torres; F A Mateos; T H Ramos; J M Arcas; A S Buño; P O'Neill
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

Review 5.  Trophic effects of purines in neurons and glial cells.

Authors:  M P Rathbone; P J Middlemiss; J W Gysbers; C Andrew; M A Herman; J K Reed; R Ciccarelli; P Di Iorio; F Caciagli
Journal:  Prog Neurobiol       Date:  1999-12       Impact factor: 11.685

Review 6.  The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases.

Authors:  H A Jinnah; L De Gregorio; J C Harris; W L Nyhan; J P O'Neill
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

7.  Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  D J Schretlen; J C Harris; K S Park; H A Jinnah; N O del Pozo
Journal:  J Int Neuropsychol Soc       Date:  2001-11       Impact factor: 2.892

Review 8.  Lesch-Nyhan disease and the basal ganglia.

Authors:  J E Visser; P R Bär; H A Jinnah
Journal:  Brain Res Brain Res Rev       Date:  2000-04

Review 9.  Attenuated variants of Lesch-Nyhan disease.

Authors:  H A Jinnah; Irene Ceballos-Picot; Rosa J Torres; Jasper E Visser; David J Schretlen; Alfonso Verdu; Laura E Laróvere; Chung-Jen Chen; Antonello Cossu; Chien-Hui Wu; Radhika Sampat; Shun-Jen Chang; Raquel Dodelson de Kremer; William Nyhan; James C Harris; Stephen G Reich; Juan G Puig
Journal:  Brain       Date:  2010-02-22       Impact factor: 13.501

10.  Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.

Authors:  J Rico-Sanz; T Rankinen; D R Joanisse; A S Leon; J S Skinner; J H Wilmore; D C Rao; C Bouchard
Journal:  Physiol Genomics       Date:  2003-07-07       Impact factor: 3.107

View more
  23 in total

1.  Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress.

Authors:  Josephine C McGowan; Collin Hill; Alessia Mastrodonato; Christina T LaGamma; Alexander Kitayev; Rebecca A Brachman; Niven R Narain; Michael A Kiebish; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2018-03-29       Impact factor: 7.853

2.  Hypoxanthine Intrastriatal Administration Alters Neuroinflammatory Profile and Redox Status in Striatum of Infant and Young Adult Rats.

Authors:  Helena Biasibetti; Paula Pierozan; André Felipe Rodrigues; Vanusa Manfredini; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-03-24       Impact factor: 5.590

3.  Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders.

Authors:  Gaia Novarino; Ali G Fenstermaker; Maha S Zaki; Matan Hofree; Jennifer L Silhavy; Andrew D Heiberg; Mostafa Abdellateef; Basak Rosti; Eric Scott; Lobna Mansour; Amira Masri; Hulya Kayserili; Jumana Y Al-Aama; Ghada M H Abdel-Salam; Ariana Karminejad; Majdi Kara; Bulent Kara; Bita Bozorgmehri; Tawfeg Ben-Omran; Faezeh Mojahedi; Iman Gamal El Din Mahmoud; Naima Bouslam; Ahmed Bouhouche; Ali Benomar; Sylvain Hanein; Laure Raymond; Sylvie Forlani; Massimo Mascaro; Laila Selim; Nabil Shehata; Nasir Al-Allawi; P S Bindu; Matloob Azam; Murat Gunel; Ahmet Caglayan; Kaya Bilguvar; Aslihan Tolun; Mahmoud Y Issa; Jana Schroth; Emily G Spencer; Rasim O Rosti; Naiara Akizu; Keith K Vaux; Anide Johansen; Alice A Koh; Hisham Megahed; Alexandra Durr; Alexis Brice; Giovanni Stevanin; Stacy B Gabriel; Trey Ideker; Joseph G Gleeson
Journal:  Science       Date:  2014-01-31       Impact factor: 47.728

4.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

5.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

6.  Evidence for gene-smoking interactions for hearing loss and deafness in Japanese American families.

Authors:  Jia Y Wan; Christina Cataby; Andrew Liem; Emily Jeffrey; Trina M Norden-Krichmar; Deborah Goodman; Stephanie A Santorico; Karen L Edwards
Journal:  Hear Res       Date:  2019-12-24       Impact factor: 3.208

7.  Transcriptome and metabolome analysis of crGART, a novel cell model of de novo purine synthesis deficiency: Alterations in CD36 expression and activity.

Authors:  Randall C Mazzarino; Veronika Baresova; Marie Zikánová; Nathan Duval; Terry G Wilkinson; David Patterson; Guido N Vacano
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

8.  Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects.

Authors:  Natchaya Vanwong; Pornpen Srisawasdi; Nattawat Ngamsamut; Nopphadol Nuntamool; Apichaya Puangpetch; Bhunnada Chamkrachangpada; Yaowaluck Hongkaew; Penkhae Limsila; Wiranpat Kittitharaphan; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2017-01-05       Impact factor: 5.810

9.  New X-chromosomal interactors of dFMRP regulate axonal and synaptic morphology of brain neurons in Drosophila melanogaster.

Authors:  Dimitrina Georgieva; Roumen Dimitrov; Meglena Kitanova; Ginka Genova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-23       Impact factor: 1.632

10.  Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma‑associated epilepsy.

Authors:  Jun Huang; Yujiao He; Mingna Chen; Juan Du; Guoliang Li; Shuyu Li; Weiping Liu; Xiaoyan Long
Journal:  Mol Med Rep       Date:  2015-09-02       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.